Cencora (WBO:ABC) Issuance of Debt: €67,499 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ABC Cencora Inc WBO:ABC
68 GF Score
Price €264.40
GF Value €251.32
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Issuance of Debt?

Cencora WBO:ABC -0.26% 68 Issuance of Debt is €67,499 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 68/100 and a GF Value™ of €251.32 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Issuance of Debt for the three months ended in Mar. 2026 was €44,767 Mil.

Cencora's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €67,499 Mil.

Cencora Issuance of Debt Related Terms

Cencora Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Cencora's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Issuance of Debt Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,915.43 5,037.67 73,438.30 63,422.62 116,419.59

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27,465.21 75,724.86 -73,402.73 20,410.01 44,766.73
WBO:ABC
68GF Score
Cencora Inc WBO:ABC
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €67,499 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €67,499 Mil mean?
Cencora (WBO:ABC) has a Issuance of Debt of €67,499 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Cencora and its competitors.
Is Cencora's Issuance of Debt too high?
Cencora's current Issuance of Debt is €67,499 Mil. Overall, Cencora has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Issuance of Debt compare to CAH and MCK?
Cencora's Issuance of Debt of €67,499 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Distribution company?
A good Issuance of Debt depends on the Medical Distribution industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Cencora and its competitors. Cencora's current Issuance of Debt is €67,499 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €251.32, compared to a current price of €264.40 — trading 5.2% above its estimated fair value. The current Issuance of Debt is €67,499 Mil. Cencora's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Issuance of Debt is €67,499 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €264.40 is trading 5.2% above its estimated GF Value™ of €251.32. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Issuance of Debt: €67,499 Mil
  • GF Value™: €251.32 vs. price of €264.40 (5.2% above fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score

Get the complete analysis for WBO:ABC

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€264.40
Price
€251.32
GF Value